Egis Atorvastatin - Dapagliflozin Egis Atorvastatin - Dapagliflozin

X

List of Related Excipient Companies and Suppliers of Atorvastatin by Basf on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
205
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Excipient based on Kollicoat® IR and monographed raw materials
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Granule / Pellet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Granule / Pellet
Category: Taste Masking
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Emulsion
Category: Topical
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Polysorbate 80
Dosage Form: Softgel Capsule
Category: Solubilizers
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Tablet
Category: Granulation
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Sodium Lauryl Sulfate
Dosage Form: Tablet
Category: Granulation
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Gel
Category: Topical
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Suppository
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Emulsion
Category: Solubilizers
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Suppository
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Tablet
Category: Solubilizers
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Softgel Capsule
Category: Solubilizers
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., JP, FCC, USP
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Dosage Form: Emulsion
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP-NF
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): Crospovidone
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ingredient(s): polyethylene glycol
Dosage Form: Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer
Technical Specifications: Not Available
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - EQ 10MG BASE
  • TABLET;ORAL - EQ 20MG BASE
  • TABLET;ORAL - EQ 40MG BASE
  • TABLET;ORAL - EQ 80MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE
  • TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE
  • TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE
  • TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE
  • TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE
  • TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY